GHR Foundation
  • Domains of Work
    • Global >
      • Children in Families
      • Prepare The Future
    • Local >
      • Catholic Education
      • Twin Cities Racial Equity (TCRE)
    • Biomedical >
      • Alzheimer's Initiative
  • News
  • About Us
    • The Foundation
    • History & Legacy
    • Team >
      • Staff
      • Committees
      • Board
    • Programs in Transition >
      • BridgeBuilder >
        • Overview
        • 2017 Top Ideas >
          • Peace Direct
          • BioCarbon Engineering
          • LIFT Chicago
          • Local Youth Corner Cameroon
          • NaTakallam
        • 2018 Top Ideas >
          • This is My Backyard
          • Found in Translation
          • Producers Direct
          • War Child Canada
          • My Choices Foundation
        • 2019 Top Ideas >
          • Top Manta
          • Five One Labs
          • SAMA for All
          • Talent Beyond Boundaries
          • FaithAction
      • Inter-Religious Action
      • Sister Support
    • FAQs
    • Grants & Financials
  • Contact

New Grant to Support Launch of APOE4 Alzheimer’s Trial

6/1/2015

 
GHR Foundation is joining forces with philanthropic and industry partners to fund groundbreaking Alzheimer’s prevention research. One such partnership is the APOE trial, a prevention study that will launch by early 2016 and last five years. GHR has partnered with the Alzheimer’s Association and Fidelity Biosciences Research Initiative to provide $10 million in new research funding to support the study.

The API APOE4 trial, conducted by the Banner Alzheimer’s Institute in Phoenix, Arizona, is focused on how two new therapies may prevent or delay the development of Alzheimer’s symptoms in a population known to be at high risk for the disease because of their age and genetic status. The trial will test two different potential approaches to see if one or both can prevent the development of memory and thinking symptoms of Alzheimer’s.

The new funding will support three aspects of the API APOE4 trial, including the expansion of the Alzheimer’s Prevention Registry, the evaluation of two remote genetic counseling approaches and new scans including Tau PET imaging, amyloid PET imaging and FDG-PET imaging. If successful, the trial will not only to evaluate investigational prevention therapies, but will help find faster ways to evaluate promising prevention therapies in the future.

To learn more about how the Foundation is targeting funding to improve some of the largest research efforts in the field, contact us.
Picture

Comments are closed.

    Categories

    All
    A4
    Alzheimer's
    Alzheimer's Association
    BridgeBuilder
    C2N
    Catholic Schools
    Children In Families
    COVID-19
    Develop Diagnostics
    DIAN Primary Prevention
    DIAN-TU
    Education
    Global Development
    Higher Education
    Inter-Religious Action
    La Jolla Institute
    Mayo Clinic
    Mayo Clinic Study Of Aging
    NIH-NIA
    Observational Studies
    Prepare The Future
    Prevention Trials
    Safeguarding
    Sister Support
    Twin Cities Racial Equity

    RSS Feed

CONNECT WITH US

NEWS  |  JOBS  | ​ CONTACT  
Privacy Policy  |  Terms of Use
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
©2023 GHR FOUNDATION
All Rights Reserved.